TWIST1 and ovarian carcinoma: Kajiyama et al. established an ovarian cancer cell line that is resistant to paclitaxel and found that these cells displayed high levels TWIST1 protein and had a greater migratory and metastatic potential compared to cells that are paclitaxel sensitive [115].